CPT code 95905 represents motor and/or sensory nerve conduction studies performed with a preconfigured electrode array, often including an F–wave study and requiring provider interpretation and a formal report. These electrodiagnostic tests are central to diagnosing peripheral neuropathies, entrapment neuropathies, and other neuromuscular disorders, and they inform clinical management and eligibility for interventions. Nationally, accurate coding and documentation for 95905 affect clinical workflows, utilization tracking, and payment consistency across payers.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for nerve conduction studies, typical sites of service, and the elements required for reporting. The publication outlines common modifier usage and payer coverage patterns where available, national benchmarking considerations, and recent policy clarifications that affect coding and claims processing. Practical takeaways include what constitutes the service, billing expectations for inclusion of F–wave studies, and items commonly audited on claims for electrodiagnostic testing. Data not available in the input will be noted where relevant.